Home » Topics » BioWorld Science

BioWorld Science
RSS

SnET2 NDA accepted for priority review

June 4, 2004

Proposed financing at InSite to advance AzaSite development

June 4, 2004

Topical vitamin B12 reported safe and effective in atopic dermatitis

June 4, 2004

Update on the pharmacokinetics and effects of the antiepileptic drug BIA-2-093

June 4, 2004

GlaxoSmithKline provides near-term outlook

June 4, 2004

Aventis delivers on submissions and approvals program during Q1

June 4, 2004

Phase IIIb trial evaluates Integrilin in early use acute coronary syndrome setting

June 4, 2004

Second successful clinical study with VR-004 for erectile dysfunction

June 4, 2004

First success-based milestone in Syrrx and Biogen Idec collaboration

June 4, 2004

Bimosiamose attenuates LAR in mild allergic asthma

June 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...